Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania

Tropical Medicine and International Health

Volumn 19, Issue 6, 2014, Pages 664-671

  Masimba, Pax ^a,b   Gare, Janet ^a   Klimkait, Thomas ^a   Tanner, Marcel ^a   Felger, Ingrid ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Drug resistance mutations; Genotyping; HIV 1; Microarray; Reverse transcriptase

Indexed keywords

ANTIRETROVIRUS AGENT; DNA FRAGMENT; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOMIC FRAGMENT; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; POPULATION RESEARCH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TANZANIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84899941800     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12289     Document Type: Article

References (11)

1. Bean P (2005) New drug targets for HIV. Clinical Infectious Diseases 41(Suppl. 1), S96-S100.
2. Crameri A, Marfurt J, Mugittu K et al. (2007) Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. Journal of Clinical Microbiology 45, 3685-3691.
3. Fehr J, Glass T, Louvel S et al. (2011) Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. Journal of Translational Medicine 9, 14.
4. Grant PM & Zolopa AR (2009) The use of resistance testing in the management of HIV-1-infected patients. Current opinion in HIV and AIDS 4, 474-480.
5. Hirsch MS, Günthard HF, Schapiro JM et al. (2008) Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clinical Infectious Diseases 47, 266-285.
6. Kaderali L, Deshpande A, Nolan JP & White PS (2003) Primer-design for multiplexed genotyping. Nucleic Acids Research 31, 1796-1802.
7. MacArthur RD (2009) Understanding HIV phenotypic resistance testing: usefulness in managing treatment-experienced patients. AIDS Reviews 11, 223-230.
8. Masimba P, Kituma E, Klimkait T et al. (2013) Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural Tanzania. AIDS Research and Human Retroviruses 29, 1229-1236.
9. Mossdorf E, Stoeckle M, Mwaigomole E et al. (2011) Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC Infectious Diseases 11, 98.
10. Shafer RW, Kantor R & Gonzales MJ (2000) The genetic basis of HIV-1 resistance to reverse transcriptase and protease inhibitors. AIDS Reviews 2, 211-228.
11. Syvänen A (1999) From gels to chips: "Minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms. Human Mutation 13, 1-10.